Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) 5-Year Yield-on-Cost % : 4.76 (As of Apr. 24, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Takeda Pharmaceutical Co 5-Year Yield-on-Cost %?

Takeda Pharmaceutical Co's yield on cost for the quarter that ended in Dec. 2023 was 4.76.

The historical rank and industry rank for Takeda Pharmaceutical Co's 5-Year Yield-on-Cost % or its related term are showing as below:

TAK' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.71 Med: 4.01 Max: 6.17
Current: 4.76

During the past 13 years, Takeda Pharmaceutical Co's highest Yield on Cost was 6.17. The lowest was 2.71. And the median was 4.01.

TAK's 5-Year Yield-on-Cost % is ranked better than
75.15% of 499 companies
in the Drug Manufacturers industry
Industry Median: 2.24 vs TAK: 4.76

Competitive Comparison of Takeda Pharmaceutical Co's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takeda Pharmaceutical Co's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's 5-Year Yield-on-Cost % falls into.

Takeda Pharmaceutical Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Takeda Pharmaceutical Co is calculated as

Yield-on-Cost

Dividend Yield %

Dividend Growth Rate)^5

Takeda Pharmaceutical Co (NYSE:TAK) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Takeda Pharmaceutical Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (NYSE:TAK) » Definitions » 5-Year Yield-on-Cost %

Comparable Companies

Traded in Other Exchanges

TKPHF:USA TAK:Mexico 4502:Japan 4502:Japan 4502:Japan 4502:Japan TKDA:Germany TKD:Germany TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.